Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Impetigo epidemiology and demographics

Introduction

Overview

Overview

In 2010, 140 million people suffered from impetigo. Impetigo is more common among children. Impetigo is more prevalent in tropical and pacific countries.[1][2][3]

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

  • In 2010, 140 million people suffered from impetigo.[3]

Prevalence

  • The prevalence of impetigo in Australian Aboriginal communities is 49%.[2]
  • The prevalence of impetigo in Solomon Islands is 43%.[4]
  • Impetigo is more prevalent in tropical and pacific countries.[1][2]
  • In 2006-2007, 25.6% school going children and 12.2% infants had active impetigo in Fiji.[1]

Age

  • Impetigo is more common among young children between age 2 to 5. Particularly those who attend school or daycare centers.[5][6][1]
  • A study showed that almost 69% of children below the age of 16 were affected by impetigo.[2]
  • Non-bullous impetigo is rare in children under 2 years.[7]

Gender

  • The distribution of impetigo is not effected by gender of the patient.

Race

  • Impetigo is very common in Australian Aboriginal communities and Solomon Islands.[2]
References

References

  1. ↑ 1.0 1.1 1.2 1.3 “High Burden of Impetigo and Scabies in a Tropical Country”.
  2. ↑ 2.0 2.1 2.2 2.3 2.4 Romani L, Steer AC, Whitfeld MJ, Kaldor JM (2015). “Prevalence of scabies and impetigo worldwide: a systematic review”. Lancet Infect Dis. 15 (8): 960–7. doi:10.1016/S1473-3099(15)00132-2. PMID 26088526.
  3. ↑ 3.0 3.1 Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M; et al. (2012). “Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010”. Lancet. 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID 23245607.
  4. ↑ Eason RJ, Tasman-Jones T (1985). “Resurgent yaws and other skin diseases in the Western Province of the Solomon Islands”. P N G Med J. 28 (4): 247–50. PMID 2940770.
  5. ↑ Hartman-Adams H, Banvard C, Juckett G (2014). “Impetigo: diagnosis and treatment”. Am Fam Physician. 90 (4): 229–35. PMID 25250996.
  6. ↑ Cohen PR (2016). “Bullous impetigo and pregnancy: Case report and review of blistering conditions in pregnancy”. Dermatol Online J. 22 (4). PMID 27617460.
  7. ↑ Pereira LB (2014). “Impetigo – review”. An Bras Dermatol. 89 (2): 293–9. PMC 4008061. PMID 24770507.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]